Investors are actively seeking information about Hims & Hers Health, Inc. (HIMS): Essential Details You Should Be Aware Of

Hims & Hers Health, Inc.: Recent Stock Activity and Outlook

Hims & Hers Health, Inc. (HIMS) has recently attracted significant attention from investors. To better understand its potential trajectory, let's examine the main factors that could influence its short-term performance.

Recent Share Performance

In the past month, HIMS shares have dropped by 47.8%. In contrast, the Zacks S&P 500 composite index saw a modest increase of 0.6%. The Medical Info Systems sector, which includes Hims & Hers Health, declined by 18.7% during the same period. This sharp decline raises questions about where the stock might be headed next.

What Drives Stock Movement?

While news and speculation can cause quick shifts in a stock's price, long-term investors typically focus on fundamental factors when making decisions. These underlying elements often have a more lasting impact on a stock’s value.

Earnings Estimate Trends

At Zacks, changes in earnings forecasts are a primary focus, as they are closely linked to a stock’s intrinsic value. When analysts revise their earnings estimates upward, it often signals improved business prospects, which can attract buyers and push the stock price higher. Research consistently shows a strong relationship between earnings estimate revisions and short-term price movements.

For the current quarter, Hims & Hers Health is projected to report earnings of $0.02 per share, a significant decrease of 90% compared to the same quarter last year. Over the past 30 days, the consensus estimate has been reduced by 76.5%.

The consensus estimate for this fiscal year stands at $0.53 per share, unchanged from the previous year, but this figure has also been revised downward by 17.6% in the last month.

Looking ahead to the next fiscal year, analysts expect earnings of $0.72 per share, which would represent a 35.7% increase from the prior year. However, this estimate has dropped by 25.1% over the past month.

The Zacks Rank, a proprietary rating system based on earnings estimate changes and other factors, currently assigns Hims & Hers Health a Rank #3 (Hold), suggesting the stock may perform similarly to the broader market in the near term.

Forward 12-Month EPS Estimate

The following chart illustrates the trend in the company’s forward 12-month consensus earnings per share estimate:

Revenue Growth Projections

Consistent revenue growth is essential for sustained earnings improvement. For the current quarter, Hims & Hers Health is expected to generate $621.4 million in sales, reflecting a 6% increase year-over-year. For the full fiscal years, revenue estimates are $2.81 billion (up 19.8%) and $3.31 billion (up 17.7%) for this year and next, respectively.

Recent Financial Results and Surprises

In the most recent quarter, the company reported revenue of $617.82 million, a 28.4% increase from the prior year. Earnings per share were $0.07, compared to $0.11 a year earlier. These results were slightly below the consensus revenue estimate by 0.22%, but the EPS exceeded expectations by 250%.

Over the last four quarters, Hims & Hers Health has beaten consensus EPS estimates twice and surpassed revenue estimates twice.

Valuation Overview

Assessing a stock’s valuation is crucial for making informed investment decisions. Comparing current valuation ratios—such as price-to-earnings, price-to-sales, and price-to-cash flow—to historical averages and industry peers helps determine whether a stock is undervalued, fairly valued, or overvalued.

The Zacks Value Style Score, which evaluates both traditional and alternative valuation metrics, assigns Hims & Hers Health a grade of B. This suggests the stock is trading at a discount relative to its peers.

Conclusion

The analysis above, along with additional resources available on Zacks.com, can help investors decide whether to pay attention to the current market buzz around Hims & Hers Health. The Zacks Rank #3 indicates the stock is likely to move in line with the overall market in the near future.